| INTRODUCTION
The major inhibitory neurotransmission in the mammalian CNS is provided by GABA A , GABA A ρ (also known as GABA C ρ receptor; see Alexander et al., 2015) , and glycine receptors (Langosch, Becker, & Betz, 1990) . In different combinations, these receptors are widely expressed throughout the nervous system and are involved in physiological functions such as cognition, learning, memory, and motor control. Disequilibrium in the functioning of GABA and glycine (Gly) receptors leads to important disorders including epilepsy, anxiety, depression, misbalance of blood pressure, sleep disorders, schizophrenia, and hyperekplexia (Johnston, Chebib, Hanrahan, & Mewett, 2003; Tan, Rudolph, & Lüscher, 2011; Sieghart, 2015; Lynch, 2004) .
The activity of GABA A receptors can be successfully regulated with allosteric modulators like benzodiazepines, including flumazenil and diazepam. They are among the most popular pharmacological drugs and are commonly prescribed to treat insomnia, anxiety, and convulsions. Benzodiazepines can potentiate GABA receptors through interaction with different sites in the receptor displaying nano-and micromolar affinities (Sieghart, 2015) . Therefore, benzodiazepine derivatives are convenient scaffolds to develop new modulators of GABA receptor function.
Light-switchable ligands have become a useful tool to specifically control ionic channels, cellular functions, the activity of neuronal circuits, and behaviour (Gorostiza & Isacoff, 2008; Kramer, Mourot, & Adesnik, 2013) . The pharmacological activity of ligands can be regulated with photochromic groups-molecules that change their configuration upon illumination with different wavelengths. Azobenzene undergoes a rapid trans-cis photoisomerization and has been widely used for this purpose. In the dark, or under visible light irradiation, azobenzene is in the elongated trans-configuration, while upon illumination with UV light (360-380 nm) , it isomerizes to its cis-state and becomes shorter by several angstroms (Gorostiza & Isacoff, 2008; Yu & Ikeda, 2004) .
With the aim of regulating the activity of GABA receptors with light, we constructed a series of azobenzene derivatives of nitrazepam and characterized their properties. Herein, we describe the interaction of one of these compounds, azobenzene-nitrazepam-1 (Azo-NZ1), with several subtypes of anion-selective Cys-loop receptors (GABA A , GABA C and glycine receptors). Azo-NZ1 successfully photocontrolled GABAergic currents in cultured cells and in brain slices, but in contrast to the intended design to obtain an allosteric ligand of the classical diazepam site, we found that the azobenzene sulfonyl group introduced alters the binding properties of the compound, enabling light-controlled blocking of the chloride-selective ion pore. Thus, Azo-NZ1 reveals a class of photochromic ligand with a structure capable of blocking the anion-selective channel pore of several Cys-loop receptors.
What is already known
• Pharmacological activity of ligands can be regulated with azobenzene photochromic group, which changes its configuration upon illumination with light of different wavelength.
What this study adds
• Azobenzene-nitrazepam based photochromic compound Azo-NZ1 is a light controllable channel blocker of heteromeric GABA A , homomeric GABA C ρ2 receptors, and α2 GlyRs.
• Azo-NZ1 modulates in a light-dependent manner synaptic GABAergic currents in dentate gyrus of hippocampal brain slices.
What is the clinical significance
2 | METHODS 2.1 | Synthesis of compounds 7-Aminonitrazepam (Guandalini et al., 2008; Severino et al., 2008) and tetrabutylammonium 4-nitrosobenzenesulfonate (Priewisch & Rück-Braun, 2005) ,4] diazepin-7-yl)diazenyl)benzenesulfonic acid) was synthesized according to the following procedure ( Figure 1b ). Tetrabutylammonium 4-nitrosobenzenesulfonate (236 mg, 0.54 mmol, 1.0 eq.) was added to a solution of 7-aminonitrazepam (68 mg, 0.27 mmol, 1.0 eq.) in acetic acid (2 ml) and CH 2 Cl 2 (1 ml). After the mixture had been stirred for 24 hr at room temperature, the solvent was removed in vacuo. 3489, 3135, 2930, 1715, 1614, 1484, 1435, 1387, 1342, 1230, 1163, 1115, 1029, 1006, 846, 742, 697 
| Cell culture and transfection
The experiments were carried out on cultured CHO cells (CHO-K1, ATCC Cat# CCL-61, RRID:CVCL_0214) obtained from the American Type Tissue Culture Collection (ATCC, Molsheim, France) that were maintained in culture conditions as previously described (Maleeva, Peiretti, Zhorov, & Bregestovski, 2017; Mukhtarov et al., 2013) . 
| Electrophysiological recordings on CHO cells
Whole-cell recordings were performed at room temperature (20-25°C) using an EPC-9 amplifier (HEKA Elektronik, Germany).
Cells were continuously superfused with external solution containing Recording pipettes were pulled from borosilicate glass capillaries (Harvard Apparatus Ltd, USA) and had resistances of 5-10 MOhms.
For the rapid replacement of the solutions, the fast application system was used. Three parallel rectangular tubes (100 × 100 μm) were posi- were excluded from analysis.
The effect of Azo-NZ1 was examined either using a "long" protocol for application of solutions, at constant holding membrane potentials (V h ) of +30 and −30 mV or using a "ramp" protocol that allowed a linear change of membrane potential from −60 to +60 mV (see Figure 3 c). For GABA C ρ2, ρ1 P2′S, and α2 glycine receptors, the controls correspond to the amplitude of the current just before application of Azo-NZ1, whereas for GABA A receptors, the control corresponds to the amplitude of the current at wash-out, due to the desensitization of this type of receptor.
UV (365 nm) LED (Thorlabs) was placed at the distance of 4-5 cm from the cell that was being receorded. The power of UV light was reaching 0.6 mW·mm −2 at the level of recording chamber, as determined using an optical power metre (Thorlabs).
| Electrophysiological recording on brain slices and electrical stimulation
Experiments were performed on white laboratory ICR outbred mice of both genders, kept at 12 hr "day"/"night" cycle. Other details are described previously (Petukhova, Ponomareva, Mukhamedyarov, Maleeva, & Bregestovski, 2018 Membrane currents were recorded at 3-10 kHz using an EPC-9 patch-clamp amplifier (HEKA Elektronik, Germany).
In granule cells of dentate gyrus, postsynaptic currents consist of two main populations: glutamatergic and GABAergic. In our experimental conditions, the reversal potentials for glutamate-and GABAinduced currents were about 0 and −50 mV, respectively. To isolate GABAergic synaptic events from glutamatergic ones without using specific pharmacological antagonists, we performed analysis of Azo-NZ1 action on eIPSCs at V h = 0 mV. At this potential, glutamatergic events are not detectable, and GABAergic currents appear as outwardly directed deflections. An application of bicuculline at the end of recordings resulted in the complete suppression of these currents, ensuring its pure GABAergic nature.
For the induction of GABAergic responses, stimulation pulses were generated by the DS3 Constant Current Isolated Stimulator (Digitimer, England). Pulses were delivered every 10 s at V h = 0 mV, the amplitudes of control eIPSCs ranged from 50 to 400 pA. Electrodes for stimulation were prepared from double-barrelled borosilicate thetatubes (OD = 1.5 mm, ID = 1.0 mm, septum = 0.2 mm, from Warner Instruments, USA). They were pulled using the programme similar to those for preparing patch-clamp recording pipettes, polished, and backfilled with aCSF. To deliver an electrical stimulus, two fine silver wires were inserted into the theta-glass.
After a whole-cell configuration had been obtained with a neuron, the stimulation electrode was placed on the granule cell layer in close proximity within the recording cell (distance 100-200 μm) located towards the hilar region. This allowed the stimulation of presynaptic fibres from the presumed GABAergic basket cells, as described by others (Haselmann, Röpke, Werner, Kunze, & Geis, 2015; Korshoej, Holm, Jensen, & Lambert, 2010) .
Previous studies demonstrated that azobenzene-based UVcontrolled molecules might be successfully used in living tissues for research purposes (Lin et al., 2015; Yue et al., 2012) . However, after prolonged exposure, UV and near-UV irradiation can be damaging (Kienzler et al., 2013) . To avoid direct illumination of brain slices with UV light, which might modify synaptic function, we illuminated the aCSF with diodes emitting either UV (365 nm) or blue (455 nm) light. The speed of the perfusion was about 20 ml·min
, and it was taking 18-20 s for the illuminated solution to arrive to the experimental chamber.
Effects of Azo-NZ1 on the amplitudes of eIPSCs were studied using the following protocol: 20-30 eIPSCs were recorded in control condition, then slices were incubated in aCSF + Azo-NZ1 for 5-10 min at visible or blue (455 nm) light (the compound in transconfiguration); the aCSF + Azo-DZ1 was illuminated with UV light for 3-5 min (switching the compound into cis-configuration); and subsequently illuminated for 3-5 min with blue light. Changes in UV/blue light illumination could be repeated several times on the same neuron before it is washed with control aCSF. Control tests showed that UV illumination of the pure aCSF for 5 min had no effect on eIPSCs.
| Data and statistical analysis
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology. Electrophysiological recordings were performed using PatchMaster (HEKA Electronic, Germany) software. To plot concentration-response curves, responses to different concentrations of GABA were fitted using a non-linear fitting routine of the Origin 7.5 software (OriginLabs, USA) with the Hill equation:
where I is the normalized current amplitude induced by the agonist at con-
max is a maximal current induced at given cell, n H is the Hill coefficient, and EC 50 is the concentration at which a half-maximum response was induced.
Ionic current recordings were analysed with Igor Pro 6.02 and Origin 9.0 software. In some cases, data were normalized to perform a comparison between different types of receptor or different agonist concentrations. Data are presented as means ± SEM. Significance of difference was evaluated by using two-sample t test, paired sample
Wilcoxon signed rank test, and Mann-Whitney U test. Differences
were considered significant at a value of P below .05.
| Materials
All the drugs were obtained from Tocris or Sigma-Aldrich (France).
Stock solutions of Azo-NZ1 (10 mM) and diazepam (50 mM) were prepared using DMSO and then diluted to the final concentration in extracellular solution. Stock solutions of GABA (1 M), glycine (1 M), 5-HT (10 mM), APV (40 mM), and bicuculline (10 mM) were prepared using MilliQ water.
| Modelling
Five different GABA receptor structures were used, all corresponding to open channel states. For GABA A receptors, we used the homology model of the heteropentameric α1/β2/γ2 receptor from reference (Bergmann, Kongsbak, Sørensen, Sander, & Balle, 2013) . Two homology models were generated for the ρ1 and ρ2 GABA A (GABA C ) receptors, using as a template the GluCl receptor in the open channel state (PDB code 3RI5; Hibbs & Gouaux, 2011) and the Swiss-Model server (Biasini et al., 2014) . The sequence identity between the GluCl template and the ρ1 and ρ2 receptors is 37% and 36.6%, and it is even higher when only the pore-lining helices are considered (54.2% and 58.3%, respectively). Indeed, GluCl has been proposed to be the best template to model the structure of GABA A ρ receptors (Naffaa, Chebib, Hibbs, & Hanrahan, 2015) . For the S2′G ρ1 and P2′S ρ2 mutant receptors, the mutation was introduced in silico using the Molefacture tool (version 1.3) in VMD (version 1.9.2; Humphrey, Dalke, & Schulten, 1996) .
While this manuscript was under review, new cryo-electron microscopy structures of GABA A receptors were published Masiulis et al., 2019) . These structures correspond to either closed or desensitized states of the receptor and hence were not used for our docking analysis Nonetheless, we superimposed the structural model of the open state used here (Bergmann, Kongsbak, Sørensen, Sander, & Balle, 2013) similarly to picrotoxinin (Gielen, Thomas, & Smart, 2015) and thus would be incompatible with a desensitized state.
| Azo-NZ1 ligand
The initial structures of the Azo-NZ1 compound (cis-and trans-isomers) were created employing Avogadro (version 1.1.1; Hanwell et al., 2012) . For each isomer, two 1,4-diazepine ring conformations, M and P, were considered, which differ in orientation (below or above the plane, respectively) of C3 and the phenyl substituent of C5
( Figure S10 ). For classical benzodiazepines that bind to the canonical allosteric site, the M conformation is the bioactive one (i.e., with higher affinity for receptor; Richter et al., 2012) . However, it is not known a priori whether Azo-NZ1 would exhibit similar conformational preferences, since it binds in a distinct site. Therefore, all four ligand structures (cis/M, cis/P, trans/M, and trans/P) were optimized using quantum mechanical calculations in order to (a) optimize the manually built ligand structures and (b) estimate the relative stability of the M and P conformers. Calculations were performed with the Gaussian 09 (G09) programme package (Frisch et al., 2013) , using density functional theory (Rajagopal & Callaway, 1973) , with the B3LYP functional (Stephens, Devlin, Chabalowski, & Frisch, 1994) and the 6-31++G(d,p) basis set. For the trans-isomer, the two conformers differ only by 0.03 kcal·mol −1 , and thus, their Boltzmann populations are very similar (51.4% and 48.6% for P and M, respectively). In other words, the two conformers can be present at room temperature. In the case of the cis-isomer, the P conformer is significantly more stable (by 3.5 kcal·mol −1 ) than the M one, and thus, it is the predominant conformer (with a Boltzmann population of 99.7%).
| Docking calculations
Autodock Vina (version 1.1.2; Trott & Olson, 2010) was employed for ligand-receptor docking. Given that experimental data indicate that Azo-NZ1 binds inside the pore, we centred our search space around the M2 helixes of the pore. A flexible docking approach was used, in which both the receptor and the ligand were considered as flexible.
On the one hand, the ligand was allowed to change its geometry (by exploring all the possible ligand torsions) in order to optimize its fit inside the pore. On the other hand, the side chains of the pore-lining residues at positions 2′, 6′, 9′, 13′, and 16′ were allowed to move and We would like to note here that, upon UV light irradiation, cis-Azo-NZ1 may either remain in the channel (assuming another binding conformation that unblocks the pore) or exit the pore (reaching the bath solution). The outcome will depend on the mean open time of the channel and the dissociation rate of cis-Azo-NZ1. Unfortunately, the dissociation rate is particularly difficult to study either experimentally or computationally. Nevertheless, we expected it to be slow, based on the observations for GABA A receptors with another pore blocker picrotoxinin (Gielen, Thomas, & Smart, 2015; Korshoej, Holm, Jensen, & Lambert, 2010) . Therefore, since with the data at hand we cannot distinguish between the two possibilities put forward above, we decided to perform docking calculations not only with trans-Azo-NZ1 but also with the cis-isomer, in order to model the situation immediately after UV irradiation. These dockings are aimed at investigating the change in the receptor-ligand binding mode upon trans-cis isomerization (both in terms of position along the pore and interactions with the pore-lining residues).
| Analysis of the docking results
We used two different approaches to pinpoint the exact binding site of Azo-NZ1. The first approach was to use the number density of the sulfonate group to follow ligand binding. Previous studies have successfully used this type of analysis to identify ligand binding sites in other ion channels (Raju, Barber, LeBard, Klein, & Carnevale, 2013) . The underlying assumption is that regions of continuous density (or high occupancy) should represent regions of tighter binding. We computed the number density value, using the Volmap plugin (Cohen, Arkhipov, Braun, & Schulten, 2006) of VMD (Humphrey, Dalke, & Schulten, 1996) . For each binding pose, the sulfonate group of Azo-NZ1 was considered a "particle" by replacing each of its atoms with a normalized
Gaussian distribution (with width 1.5 times its atomic radius) and additively distributing those Gaussians on a three-dimensional grid (with dimensions 0.5 × 0.5 × 0.5 Å 3 ). The resulting particle density is thus equivalent to the number of binding poses whose sulphonate group is located in a given volume of the pore.
The second approach was based on the analysis of the receptorligand interactions. First, the ligand binding poses were clustered using the quality threshold algorithm implemented in VMD (https://github. com/luisico/clustering), and then the representative structure of the most populated cluster(s) was analysed using the Binana algorithm (Durrant & McCammon, 2011) . The images of the modelling section were generated with UCSF Chimera (Pettersen et al., 2004) or VMD (Humphrey, Dalke, & Schulten, 1996) .
| Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMA-COLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017) .
The design of our photochromic ligand was based on the diazepam structure ( Figure 1a ), a widely used modulator of GABAergic function.
Benzodiazepines are capable of binding in several interaction sites in the receptor (Middendorp, Maldifassi, Baur, & Sigel, 2015; Sieghart, 2015) , and this offers, in principle, greater flexibility to introduce relatively bulky substitutions like azobenzene without leading to a loss of functional activity of the compound. This choice was strengthened by the fact that the benzodiazepine nitrazepam, a diazepam derivative (Figure 1a ), can be easily functionalized for a subsequent Mills reaction via reduction of its nitro-group (Severino et al., 2008) and thus be directly incorporated as part of the azobenzene (Figure 1b) .
Therefore, the nitro-group of nitrazepam was reduced providing an aniline, which was used for further functionalization to set up the azobridge in a Mills-type reaction (see Section 2). To increase the solubility of the azo-nitrazepam, sulfanilic acid was used as precursor for the formation of the nitroso compound (Priewisch & Rück-Braun, 2005) providing a negative charge at physiological pH values (Kim, Gao, & Burgess, 2009 ). This compound showed robust photochromism with a preference for the trans-configuration in darkness and under visible light (455 nm), while under UV illumination (365 nm), the cisconfiguration is favoured (Figures 1c,d and S11).
3.2 | Action of Azo-NZ1 on heteromeric GABA A α1/β2/γ2 receptors Analysis of the GABA dose/response curves showed that EC 50 for α1/β2/γ2 GABA A receptors was 8 ± 3 μM (Figure 2a ; n = 6), which was close to the previously reported values (Fisher, 2004) . Diazepam (10 μM) co-applied with non-saturating concentration of GABA caused an increase in the current amplitude (Figure 2b) , which is in accordance with previous observations (Bormann & Clapham, 1985) . the amplitude of GABA-induced currents decreased by 78% and 51%
at +30 mV and −30 mV, respectively (Figure 2c ). Analysis of concentration dependencies of Azo-NZ1 action shows that at −30 mV, the IC 50 was 67 ± 5 μM (n = 6; Figure 2d ), and thus, further experiments were performed with concentrations of Azo-NZ1 close to IC 50 .
Using a "ramp" protocol ( Figure 3c , inset), we have shown that, under visible light, 50-μM Azo-NZ1 decreased currents induced by 5-μM GABA by 76 ± 5% and 40 ± 4% at +60 mV and −60 mV, respectively (n = 5, P < .05), confirming that Azo-NZ1 is more efficient at positive potentials (Figure 3c ). The recovery during UV illumination was not complete (P < .05), presumably, because of incomplete photoswitching of Azo-NZ1 in cis-configuration.
The voltage dependence of the inhibitory action of Azo-NZ1 suggested that the compound might act as an open channel blocker of GABA A receptors (Maleeva, Peiretti, Zhorov, & Bregestovski, 2017) .
To test this hypothesis, we compared the action of Azo-NZ1 at different concentrations of the agonist. The amplitude of currents induced by GABA concentration below EC 50 (5 μM) was decreased by application of Azo-NZ1 (50 μM) (Figure 3a,d) . Azo-NZ1 co-applied with saturating concentration of GABA (300 μM) produced an even stronger inhibitory effect (Figure 3b,d) 3.3 | Action of Azo-NZ1 on homomeric ρ1 and ρ2 GABA A (GABA C ) receptors
To further investigate the hypothesis that Azo-NZ1 acts as a blocker of the GABA receptor channels without interacting with the diazepambinding site located at the α/γ subunits interface, we analysed the action of this photochromic ligand on benzodiazepine-insensitive ρ1
and ρ2 GABA A (GABA C ) homomeric receptors. Concentrationdependency analyses showed that the EC 50 for GABA of ρ1 and ρ2
GABA C receptors were similar (Figure 4a ). In accordance with previous observations (Ragozzino et al., 1996) , GABA-induced currents mediated by these receptors do not exhibit desensitization and are characterized by a very long deactivation period after agonist application.
We found that Azo-NZ1 did not alter the activity of human ρ1 GABA C receptors (Figure 4b ), but it enabled robust photoswitching of ρ2 receptors (Figure 4d ). The IC 50 for GABA ρ2 receptors comprised 128 ± 25 μM (n = 6), and thus, all the experiments with ρ2
receptors were performed at 100 μM of Azo-NZ1, as this concentration was close to IC 50 (Figure 4f ). Under visible light, currents induced by saturating GABA concentration (10 μM) were decreased by 100-μM Azo-NZ1 at −30 and +30 mV, respectively (Figure 4d,e) , that is, the inhibitory action of Azo-NZ1 on ρ2 receptors is also voltagedependent. UV illumination restored the amplitude of the current to the nearly control values. The amplitude of ρ2 currents induced by 10 μM of GABA without addition of Azo-NZ1 was not affected by UV illumination (Figure 4c ).
| Molecular determinants of Azo-NZ1 action
The well-defined voltage dependence of the Azo-NZ1 effect on GABA A and GABA C ρ2 receptors and its independence on the (Xie, Song, Ripps, & Qian, 2008 ). An amino acid sequence alignment showed that TM2 domains of ρ1 and ρ2 subunits differ by the amino acids at the position 2′: ρ1 contains proline while ρ2 contains a serine residue (Figure 5a ).
To check the putative role of the 2′ residue in Azo-NZ1 sensitivity, we substituted proline by serine at position 2′ of the ρ1 subunit. P2′S mutation did not affect the apparent affinity of the ρ1 receptor to GABA (EC 50 = 0.98, n = 4) but made it sensitive to the action of Azo-NZ1. Under visible light, 100-μM Azo-NZ1 inhibited currents induced by saturating concentrations of 10-μM GABA (Figure 5b,c) .
UV illumination caused recovery of currents to 97 ± 1% and 90 ± 3%, respectively (Figure 5b ).
Thus, we confirmed that Azo-NZ1 in its trans-configuration interacts with the pore of GABA receptors and identified the 2′ position of the TM2 domain as key determinant of the light-dependent action of Azo-NZ1. This conclusion was additionally confirmed in experiments demonstrating that the S2′G mutation in the ρ2 subunit influenced its interaction with Azo-NZ1. Upon application of Azo-NZ1 currents amplitude decreased by 14 ± 2% (Figure 5d , n = 5, P < .05), which might be due to weak interaction between Azo-NZ1 and mutant receptor; importantly, UV effect was virtually absent. Results of the modelling analysis presented below are in line with our observations.
3.5 | Interaction of Azo-NZ1 with other members of Cys-loop receptor family GABA receptors and glycine receptors belong to the Cys-loop receptors family and amino acid sequences forming their Cl-selective pores are highly similar ( Figure S1A ). Thus, we asked if Azo-NZ1 also acted as a glycine receptor channel blocker.
Trans-Azo-NZ1 produced only minor inhibitory effect in α1 glycine receptors-the current amplitude was reduced to 86 ± 3% ( Figure S1B , n = 4, P < .05), with slightly stronger reduction upon illumination with UV light (to 73 ± 2%, P < .05). In contrast, in α2 glycine receptors, Azo-NZ1 induced a prominent decrease of the current amplitude (to 23 ± 3%, n = 10, P < .01) that was altered by UV illumination (95 ± 7%, P < .01, n = 10; Figure S1B ,C). The profile of α2 glycine receptor interaction with Azo-NZ1 strongly resembles the one of GABA A and GABA C receptors, suggesting the same pore-blocking mechanism of action.
In order to have a wider view of Azo-NZ1 selectivity profile, we also tested it in a cation-selective member of Cys-loop receptor family, the 5HT 3 A receptor. In contrast to GABA receptors and glycine receptors, Azo-NZ1 in trans or cis-configurations did not interact in a specific manner with 5-HT3A receptors ( Figure S2 , Supplementary Text). Thus, Azo-NZ1 selectively interacts with anion-permeable channels of the Cys-loop receptor family, exhibiting a subunit specificity based on the nature of 2′ residues in TM2 pore.
| Modelling of Azo-NZ1 molecular interactions with GABA receptors
To get further insights into the mechanism of action of Azo-NZ1 in GABA receptors, we performed molecular docking calculations. In view of the mutagenesis results indicating the relevance of the 2′ residues, the docking was carried out in the transmembrane region of the ion channel pore. Four different GABA C receptor structures were used:
wild-type ρ2, S2′G ρ2 mutant, wild-type ρ1, and P2′S ρ1 mutant (see Section 2); all structures were modelled in the open channel state.
Docking of trans-Azo-NZ1 to the GABA C ρ2 receptor (Figure 6a) showed that the preferred binding site of the sulfonate group is located in the narrow 2′ position of the pore region ( Figure S3A formed by the cis-and trans-isomers of Azo-NZ1 with residues of the transmembrane domain of ρ2 GABA C receptor the pore diameter at the level of the 2′ serine ring, thus creating an obstacle that hinders the passage of the chloride ions through the pore both sterically and electrostatically ( Figure S4 ). Interestingly, the negatively charged sulfonate group occupies the same position as the chloride ion trapped in X-ray structures of GABA A receptor (Laverty et al., 2017) and glycine receptor (Du, Lü, Wu, Cheng, & Gouaux, 2015) . Altogether, the architecture of trans-Azo-NZ1 fits perfectly in the pore region of the GABA C ρ2 receptor.
In contrast, the position of the sulfonate group of cis-Azo-NZ1 is more scattered all over the 2′-13′ region of the pore ( Figure S3B ), and the number of poses with the sulfonate group in the 2′ region (i.e., the ones able to block the pore) is decreased by half. Analysis of the preferred binding pose of the ligand (Figure 6c) shows that, due to the staple-like shape of cis-Azo-NZ1, the ligand is preferentially located further up in the pore and the number of interactions with the receptor is dramatically decreased compared to the trans-isomer (Figure 6d ). The ligand forms only one hydrogen bond with the pore residues, involving the tertiary amine of the benzodiazepine core and one hydroxyl group of T13′, and most importantly, the sulfonate group does not form any interaction with the pore-lining residues, since it is positioned near L9′. The smaller number of interactions of the cis-isomer compared to trans indicates that the ligand will have a higher probability of dissociation upon UV irradiation. Moreover, the ligand is mostly placed in the regions where the diameter of the pore is wider (around 11 Å, see Figure S4 ), and thus, it cannot block chloride conduction by either steric or electrostatic effects. Therefore, we predict that, even if cis-Azo-NZ1 remains bound, it would not decrease the channel current of the receptor. These results explain the higher capability of trans-Azo-NZ1 to block the pore of the GABA C ρ2 receptor compared to the cis-isomer.
The importance of 2′ residues is also corroborated by the results obtained for the S2′G ρ2 mutant. In this case, the sulfonate group cannot form hydrogen bonds with the 2′ residues. As a consequence, the population of trans-Azo-NZ1 in the 2′ region decreases and the ligand is no longer able to block the pore ( Figures S5B and S6A) . Similar results were also obtained for the ρ1 receptor, which has proline at the 2′ region ( Figures S6B and S7A) . Conversely, mutation of proline to serine (P2′S) in the ρ1 receptor increases the population of the sulfonate in the 2′ region ( Figure S7B ) with respect to the WT receptor ( Figure S7A ). The associated binding mode of Azo-NZ1 to P2′S ρ1 ( Figure S6C ) is very similar to the one for wild-type ρ2 (Figure 6 ), consistent with the appearance of inhibition observed in our experiments ( Figure 5 ).
We also performed docking calculations for the heteromeric α1/β2/γ2 GABA A receptor, using a model of the open channel state (Bergmann, Kongsbak, Sørensen, Sander, & Balle, 2013) . For this receptor, the density analysis results are noisier due to the heterogeneous subunit composition ( Figure S8A ). Therefore, we can only say with certainty that the trans-Azo-NZ1 binding mode with the sulphonate bound at position 2′ is the most likely, similar to homomeric ρ2 GABA C receptor. Even though there is only one serine in this region (belonging to the γ2 subunit), the hydrogen bond interaction with the ligand is still present ( Figure S8B ). Moreover, although α1-Val2′ and β2-Ala2′ are not able to form hydrogen bonds, their volume is similar to that of Ser and thus still compatible with sulphonate binding at position 2′. In addition, the hydrogen bond between the carbonyl group of Azo-NZ1 and T13′ is also maintained ( Figure S8B ).
As a result, trans-Azo-NZ1 is clamped in the pore of the GABA A receptor ( Figure S8C ), as it was in the GABA C ρ2 receptor ( Figure 6b ) and thus is able to block chloride conduction.
Altogether, these observations demonstrate that Azo-NZ1 is a photoswitchable blocker of GABA A and GABA C receptors, whose trans-configuration interacts with residues located in the pore, in particular at positions 2′ and 13′. In trans-Azo-NZ1, the distance between the sulphonate group and the carbonyl group of the benzodiazepine core is optimal for Azo-NZ1 to get clamped between these two residues, enabling pore blocking.
| Effect of Azo-NZ1 on synaptic currents in brain slices
Finally, to evaluate Azo-NZ1 as photochromic modulator of GABAergic synaptic events, we performed electrophysiological recordings from neurons in dentate gyrus granular layer, which possess a strong GABAergic synaptic inputs (Coulter & Carlson, 2007; Haselmann, Röpke, Werner, Kunze, & Geis, 2015) .
Whole-cell recordings were performed at V h = 0 mV and stimulation pulses induced by theta pipettes delivered at frequency 0.1 Hz, inducing a reliable GABAergic eIPSCs, which exhibited relatively low run-down (about 20%) during long-lasting recordings (>1 hr). In control conditions, amplitudes of eIPSCs varied in different neurons between 50 and 400 pA (n = 10).
For the neuron illustrated in the Figure 7a ,b, amplitude of eIPSCs in control aCSF was 156.9 ± 4.5 pA, and it decreased to 100.6 ± 3.2 pA after addition of 100-μM Azo-NZ1. Switching to the solution pre- at GABA receptors as they are the predominant subtype of inhibitory ligand-gated receptors in higher brain regions (Bowery et al., 1984; Sieghart & Sperk, 2002) .
| Azo-NZ1 as Cl-channel blocker
Surprisingly, in our experiments, Azo-NZ1 caused an inhibitory effect on the GABA A receptor, contrary to the potentiating effects via benzodiazepines binding sites. Moreover, similar inhibition was observed for GABA ρ2, which lacks the classical benzodiazepine site (Sieghart, 2015) , and for α2 glycine receptors. While we cannot entirely rule ii. the effect of Azo-NZ1 is voltage dependent, being much stronger at positive membrane potentials;
iii. mutation in the ρ1 GABA C receptor of a single amino acid situated at the 2′ level of the ion pore (P2′S) resulted in the appearance of blocking activity of Azo-NZ1, with features similar to GABA C ρ2 receptors;
iv. the S2′G mutation in ρ2 subunits resulted in the loss of the Azo-NZ1 specific activity;
v. molecular docking calculations show that the length of trans-Azo-NZ1 fits in the pore region, with the sulfonate group blocking ion passage at the 2′ region.
In our experiments, we have achieved a robust photoswitching effect using Azo-NZ1. Upon UV irradiation, currents recovered to 85-97%. The remaining 15-3% might be explained by not complete switching of trans-Azo-NZ1 into cis-state, not complete dissociation of cis-Azo-NZ1 form the pore, or fast development of the receptor desensitization.
| Possible mechanism of Azo-NZ1 interaction with the channel
The 2′ residue of the TM2 domain (see Figure 5a ) is a key region that determines the action of several pore blockers of Cys-loop receptors, including cyanotriphenylborate (Rundström et al., 1994) , picrotoxin (Lynch, Rajendra, Barry, & Schofield, 1995; Zhorov & Bregestovski, 2000) , niflumic acid (Maleeva, Peiretti, Zhorov, & Bregestovski, 2017) , and cyclothiazide (Xie, Song, Ripps, & Qian, 2008) . The Azo-NZ1 construct contains two features that are essential to impart sensitivity to the photochrome: (a) the negative charge of the sulphonate group (mimicking that of the chloride ion) and (b) the distance between this sulphonate group and the carbonyl group of the benzodiazepine core (see Figure S2 ). In trans-Azo-NZ1, this distance is optimal (~14.1 Å) to bridge the two pore-lining hydrogen bond residues S2′ and T13′. Upon UV light irradiation, cis-Azo-NZ1 may either remain in the channel (assuming another binding conformation that unblocks the pore) or exit the channel (reaching the bath solution).
Although with the data at hand we cannot distinguish between the two possibilities, it is feasible that cis-Azo-NZ1 remains partially bound in the pore, as can be suggested from Figures 3c and 7b and modelling analysis ( Figure 6c ).
| Effect of Azo-NZ1 on synaptic currents
Our analysis on dentate gyrus neurons from mouse brain slices demonstrated that Azo-NZ1 decreases amplitude of GABAergic synaptic events in a light-dependent manner. The inhibition was weaker in comparison with the one observed at heterologously expressed α1/β2/γ2 GABA A receptors. This may result from the different composition of GABA receptors receptors present in the dentate gyrus neurons, which can express up to 10 GABA A receptor subunits, as
single-cell mRNA analysis demonstrated (Brooks-Kayal, Shumate, Jin, Rikhter, & Coulter, 1998; Coulter & Carlson, 2007) . Also, synaptic and extrasynaptic GABA A receptors with distinctive properties and subunit composition can be differently modulated by the photochrome. The role of these discrepancies in the neuronal circuit modulation by Azo-NZ1 should be clarified in future studies.
Recently, several photochromic modulators of GABA A receptors were developed (reviewed in Bregestovski, Maleeva, & Gorostiza, 2018) : two potentiators (Stein et al., 2012; Yue et al., 2012) and several inhibitors (Huckvale, Mortensen, Pryde, Smart, & Baker, 2016; Lin et al., 2014 Lin et al., , 2015 Lin, Tsai, Rajappa, & Kramer, 2018) Moreover, Azo-NZ1 is the first known photochromic modulator of ρ2 GABA C receptors that are highly expressed in retina. Azo-NZ1 blocks as well α2 glycine receptors in a similar UV-dependent manner, probably due to highly conserved amino acid sequences of pore-forming domains of GABA and glycine receptors. Indeed, the difference in Azo-NZ1 action on α1 and α2 glycine receptors, caused by glycine to alanine substitution in 2′ position of their TM2 domains, confirms the pore-blocking effect of Azo-NZ1. In contrast, Azo-NZ1 was not able to block the 5-HT 3 A receptor, a cation-selective member of Cys-loop receptor superfamily.
Our findings pave the way for development of a novel pharmacological toolset for photo-modulation, as well as functional and molecular physiology studies of these receptors. Azo-NZ1 is a freely diffusible ligand that binds to endogenous receptors, and such studies could be carried out without any genetic manipulations. Photocontrol of inhibitory neurotransmission should be readily accessible in acute preparations and in all kinds of vertebrate and invertebrate wild-type animals using Azo-NZ1.
